Events

This live virtual activity will cover the care and treatment of patients with moderate to severe atopic dermatitis.

This live activity will cover early detection and intervention in prostate cancer.

This program will review current and emerging immunotherapies for the management of patients with advanced NSCLC.

This live, case‐based activity targets health care gaps related to the underlying autoimmune causes of alopecia areata (AA) and targeted treatment approaches, which can have a profound impact on health‐related quality of life through burden of disease and associated comorbidities.

This live activity will cover early detection and intervention in prostate cancer.

The case-based virtual live activity will cover the treatment and management of patients with chronic and diabetic kidney disease.

This live virtual activity will cover the care and treatment of patients with moderate to severe atopic dermatitis.

This live virtual activity will cover the care and treatment of patients with moderate to severe atopic dermatitis.

This live virtual activity targets healthcare gaps related to the treatment and management of atrial fibrillation (AF), impacting outcomes through guidelines and best practices, appropriate antiarrhythmic use, and shared decision-making.

This live, case‐based activity targets health care gaps related to the underlying autoimmune causes of alopecia areata (AA) and targeted treatment approaches, which can have a profound impact on health‐related quality of life through burden of disease and associated comorbidities.

The COVID-19 FRONTLINE Grand Rounds series provides a comprehensive and up-to-date perspective on the ever-changing management of patients with COVID-19. Each Grand Rounds session features in-depth case studies to encourage retention of the lessons and provide new perspectives on the management of patients during the COVID-19 pandemic. This program will focus on optimizing outcomes for hospitalized and nonhospitalized patients with COVID-19 through the use of novel agents authorized for emergency use.

This live activity will cover early detection and intervention in prostate cancer.